Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
(AP) - Pfizer Inc. said Friday European regulators have approved a new version of its children's pneumococcal vaccine, Prevenar 13. Full Article at NewYorkBusiness.com
-
Main Category: Infectious Diseases / Bacteria / Viruses Also Included In: Regulatory Affairs / Drug Approvals Article Date: 11 Dec 2009 - 2:00 PST email to a friend printer friendly view / write opinions rate article Protalix Biotherapeutics,... Full Article at Medical News Today
-
NEW YORK -- (BUSINESS WIRE) -- The European Commission has granted Pfizer Inc. (NYSE: PFE) a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Full Article at Freshnews.com
-
2009-12-11 12:29:32 - NEW DELHI, INDIA -- (Marketwire) -- 12/11/09 -- U.S. stocks ended higher on Wednesday as the U.S. dollar fell and investors' appetite for risk returned, lifting shares of financial, technology and natural resource... Full Article at PR-Inside.com
-
LONDON -- Pfizer Inc. said Friday that it has been granted a European marketing authorization for its Prevenar 13 vaccine. Full Article at FOX News
-
The European Commission has granted Pfizer Inc. (NYSE: PFE) a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Full Article at News-Medical.net
-
LONDON (MarketWatch) -- Pfizer Inc. /quotes/comstock/13*!pfe/quotes/nls/pfe (PFE 18.32, +0.08, +0.44%) said Friday that it has been granted a European marketing authorization for its Prevenar 13 vaccine. Full Article at MarketWatch
-
Pfizer today announced results from an exploratory analysis of the Intergroup Exemestane Study (IES) at a median follow-up of 91 months in estrogen-receptor positive (ER+) or estrogen-receptor unknown (ER-unknown) women that looked at breast cancer... Full Article at News-Medical.net
-
Zentiva, a Czech pharmaceutical company, will start manufacturing generic version of Pfizer’s Viagra. The production will begin in 2010. Full Article at Pharmaceutical Business Review
-
Cover your market cap bases with a mix of small-, mid- and megacap companies. Spread your exposure across various sectors, such as information technology, consumer staples, and health care, for example. Full Article at The Money Times
-
Cover your market cap bases with a mix of small-, mid- and megacap companies. Spread your exposure across various sectors, such as information technology, consumer staples, and health care, for example. Full Article at The Money Times
-
“U.S. securities regulators are investigating at least nine mergers, including Pfizer Inc.’s takeover of Wyeth and Merck & Co Inc.’s acquisition of Schering-Plough Corp, for possible insider-trading violations, the Wall Street Journal reported, citing... Full Article at Rational Review
-
Pfizer will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. Full Article at World Pharma News
-
A Pfizer official has confirmed with WPTZ.com that layoff notices are going out at its Rouses Point facility Thursday and Friday. 200 Lose Jobs; More Expected ROUSES POINT, N.Y. -- A Pfizer official has confirmed with WPTZ.com that layoff notices... Full Article at WPTZ Plattsburgh
-
A new U.S. securities regulatory investigation into potential insider trading began in mid-November with the issuance of subpoenas to a number of hedge funds that may have gotten an advance word on corporate takeovers, said people familiar with the... Full Article at The Post Chronicle
-
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT. It was the best of times, it was the worst of times. Full Article at Motley Fool
-
Pfizer is suing India's Dr Reddy's Laboratories in a Delaware federal court over a proposed generic version of the blockbuster cholesterol med Lipitor, according to Livemint. Full Article at FiercePharma
-
Pfizer's (PFE) new cancer drug Aromasin has been shown in studies to reduce relapse in 19% of breast cancer patients, who switched to the drug after taking tamoxifen, versus those who stayed on tamoxifen for five years. Full Article at FOX News
-
Wilmington, Delaware: Drug maker Pfizer Inc. sued Dr Reddy’s Laboratories Ltd, asking a judge to prohibit sales of generic versions of its best-selling anti-cholesterol medicine Lipitor until 2017. Full Article at livemint.com
-
NEW YORK (Reuters) - A new U.S. securities regulatory investigation into potential insider trading began in mid-November with the issuance of subpoenas to a number of hedge funds that may have gotten an advance word on corporate takeovers, said people... Full Article at The Washington Post
About Pfizer Inc.
Wikipedia
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. Full Article
Related Photos
prev
next
-
Reuters Pictures
Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (L), in New York, August 6, 2009.
View Photo » -
Reuters Pictures
Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, August 6, 2009.
View Photo » -
AP Photo
Graphic shows 2008 sales for selected Pfizer drugs.
View Photo » -
AP Photo
Graphic shows 2008 sales for selected Pfizer drugs.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler, Chairman and CEO of Pfizer, smiles during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.
View Photo » -
Reuters Pictures
Jeffrey Kindler, Chairman and CEO of Pfizer, speaks during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler, Chairman and CEO of Pfizer, smiles during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler, (L) Chairman and CEO of Pfizer and Bernard Poussot, Chairman and CEO of Wyeth, speak during a press conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Reuters Pictures
Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, speak during a news conference announcing the merger of the two companies in New York, January 26, 2009.
View Photo » -
Getty Images
NEW YORK - JANUARY 22: (FILE PHOTO) The Pfizer building is seen January 22, 2007 in New York City.
View Photo » -
Getty Images
NEW YORK - APRIL 17: (FILE PHOTO) Pedestrians walk past the world headquarters of Pfizer Inc. April 17, 2008 in New York City.
View Photo » -
AP Photo
Jeffrey Kindler, chairman and CEO of Pfizer, speaks at a news conference Monday, Jan. 26, 2009, in New York.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: A Pfizer sign hangs on the outside of their headquarters after a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion, creating the world's largest biopharmaceutical company.
View Photo » -
Getty Images
NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.
View Photo »
Reuters Pictures
Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, August 6, 2009.
View Photo »Related Topics
Related Videos
Related Quotes
- Previous
- Next
- 1/22
-
My stepmother would say: ‘He has it all in T-bills. He’s buying new stuff.’ It looked like stock in Coca-Cola, Pfizer, Google, Microsoft, IBM. It wasn’t like a laser printout you’d get from Smith Barney
SOURCE: Only the Blog Knows Brooklyn -
I am delighted to be collaborating with Pfizer’s exceptional oncology group ... I am also very happy that Pfizer is focusing on and dedicating resources to address a very important unmet medical need for the Asian populations. This new collaboration extends an already very successful partnership between...
SOURCE: News-Medical.net -
Most recently (Pfizer paid) a whopping $2.3 billion for fraudulently marketing Bextra, a painkiller withdrawn from the market in 2005, and three other drugs.
SOURCE: Canada.com -
With the exception of Pfizer Inc's rifabutin, a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS, there have been no newly licensed drugs for TB in 40 years
SOURCE: Medical News Today -
Do you think Pfizer [which makes Viagra] is going to stand idly by when X-Excite -- a faster, safer and all around better drug -- takes the erectile dysfunction market by storm?
SOURCE: Vancouver Sun -
We will be developing, manufacturing and supplying pharmaceutical products in India for Pfizer. There are no talks for any alliance or on (manufacturing of) Lipitor
SOURCE: DNA India -
Pfizer’s top executives who visited India last week had met Cipla management for discussing a possible collaboration
SOURCE: livemint.com -
While we are encouraged Cerezyme shipments have begun as planned, we think long-term implications to GENZ's LSD franchise remain dynamic. Specifically, with Fabrazyme supply constraints continuing well into 2010, and now Pfizer (NYSE: PFE) joining forces with Protalix, we see continued pressure on this ...
SOURCE: Street Insider -
By combining our respective strengths to advance this innovative therapy, Pfizer and Protalix expect to quickly deliver an alternative treatment for people suffering from Gaucher’s disease
-
Japan wants quality assurance and credibility for generic medicines and Pfizer has them
SOURCE: Bloomberg.com -
Pfizer, Merck and IPCA have appointed medical representatives on contract to work in rural areas. Most of these marketing personnel get only commission. The model works well as companies do not incur any additional cost
SOURCE: Business Standard -
Bringing Pfizer to New London came at a heavy cost to taxpayers
SOURCE: TheDay.com -
So in these cases we had people with breast cancer and associated damages, I think in the Pfizer cases there were awards of up to $4 million for compensatory damages but awards of say up to $70 million for punitive. So the compensatory component would be available to people in this country.
SOURCE: ABC Online -
Pfizer might part with its recently acquired Wyeth baby-food business ... It's all formula, which Heinz loves; there would be no antitrust concerns; and it's not as big as Mead Johnson.
SOURCE: Pittsburgh Entertainment -
The leadership contributions from SFU, Pfizer Canada, the Heart and Stroke Foundation and the anonymous donor to St. Paul's Hospital Foundation for this Chair will have a dramatic impact on heart disease prevention at St. Paul's Hospital and SFU, improving the health of people in B.C. and beyond
SOURCE: News-Medical.net -
The approval of Revatio injection is a clear demonstration of Pfizer’s commitment to developing treatments addressing the unmet needs of patients with pulmonary arterial hypertension. This important milestone highlights the Specialty Care business unit’s dedication to advancing treatments for serious an...
SOURCE: Pharmaceutical Business Review -
Now if you'll excuse me, I have to go eat lunch with representatives from Goldman Sachs, Wells Fargo and Pfizer.
SOURCE: The Politico -
The Southeastern Pennsylvania Transportation Authority has agreed to cover almost all of its rising health-care costs, and to increase coverage for Pfizer’s (PFE) Viagra and other erectile dysfunction treatments, the Philadelphia Daily News reports. Workers are unhappy that their health insurance plan o...
SOURCE: The Business Insider -
Today’s announcement that Pfizer is closing its research facility in New London demonstrates the folly of government plans that involve massive corporate welfare and that abuse eminent domain for private development. The majority opinion in Kelo v. New London described the Fort Trumbull project as a ‘ca...
SOURCE: Queens Crap -
How wonderful would it be that the remediation of Pfizer be included in the rezoning of the Broadway Triangle
– Diana Reyna SOURCE: New York Post -
The announced closing of the New London site eight years after it opened to great fanfare came as a blow to a city that had counted on Pfizer’s multimillion-dollar facility to help revive its fortunes
SOURCE: The Wonkster -
California has always been a leader in biotech research and innovation and Pfizer's announcement that it will establish California as one (of) the five hubs of its worldwide R&D network is fantastic news for our state ... Today's announcement will not only ensure that our state continues as a leader in ...
SOURCE: 10news.com San Diego
– Related Conversations
There are no results for this module. Edit the module to change the search term used to query Twitter.